Authors:
Carnazzi, E
Aumelas, A
Mouillac, B
Breton, C
Guillou, L
Barberis, C
Seyer, R
Citation: E. Carnazzi et al., Design, synthesis and pharmacological characterization of a potent radioiodinated and photoactivatable peptidic oxytocin antagonist, J MED CHEM, 44(18), 2001, pp. 3022-3030
Authors:
Breton, C
Chellil, H
Kabbaj-Benmansour, M
Carnazzi, E
Seyer, R
Phalipou, S
Morin, D
Durroux, T
Zingg, H
Barberis, C
Mouillac, B
Citation: C. Breton et al., Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist - Comparison with the human V-1a vasopressin receptor, J BIOL CHEM, 276(29), 2001, pp. 26931-26941
Authors:
Durroux, T
Peter, M
Turcatti, G
Chollet, A
Balestre, MN
Barberis, C
Seyer, R
Citation: T. Durroux et al., Fluorescent pseudo-peptide linear vasopressin antagonists: Design, synthesis, and applications, J MED CHEM, 42(7), 1999, pp. 1312-1319
Authors:
Tran, D
Stelly, N
Tordjmann, T
Durroux, T
Dufour, MN
Forchioni, A
Seyer, R
Claret, M
Guillon, C
Citation: D. Tran et al., Distribution of signaling molecules involved in vasopressin-induced Ca2+ mobilization in rat hepatocyte multiplets, J HIST CYTO, 47(5), 1999, pp. 601-616
Authors:
Tran, D
Durroux, T
Stelly, N
Seyer, R
Tordjmann, T
Combettes, L
Claret, M
Citation: D. Tran et al., Visualization of cell surface vasopressin V1a receptors in rat hepatocyteswith a fluorescent linear antagonist, J HIST CYTO, 47(3), 1999, pp. 401-409
Authors:
Phalipou, S
Seyer, R
Cotte, N
Breton, C
Barberis, C
Hibert, M
Mouillac, B
Citation: S. Phalipou et al., Docking of linear peptide antagonists into the human V-1a vasopressin receptor - Identification of binding domains by photoaffinity labeling, J BIOL CHEM, 274(33), 1999, pp. 23316-23327